Overview

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-06-24
Target enrollment:
Participant gender:
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C714 and C714R in healthy adults
Phase:
PHASE1
Details
Lead Sponsor:
AJU Pharm Co., Ltd.
Treatments:
Drug Evaluation